首页 > 市场调查报告书 > 医疗设备

e保健

市场调查报告书

商品编码

1676236

全球感染监测解决方案市场研究报告 - 产业分析、规模、份额、成长、趋势和预测 2025 年至 2033 年

Global Infection Surveillance Solutions Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

出版日期: 2025年03月01日 | 出版商:

Value Market Research | 英文 112 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球感染监测解决方案市场规模预计将从 2024 年的 5.8709 亿美元增长到 2033 年的 18.3445 亿美元，在 2026 年至 2033 年的预测期内呈现强劲的 0.135% 的年复合成长率(CAGR)。

受医疗保健环境对有效感染控制和预防策略的需求不断增长的推动，感染监测解决方案市场有望大幅成长。随着全球医院内感染（HAI）负担不断上升，医疗机构正在优先实施强大的监测系统来监测和管理感染爆发。这些解决方案使医疗保健提供者能够收集、分析和报告感染率资料，促进及时介入并提高病人安全。资料分析、人工智慧和机器学习方面的创新正在增强感染监测系统的功能，实现即时监控和预测分析，从而可以在疫情升级之前识别潜在的疫情。

此外，对法规遵循和品质改进措施的日益重视正在影响感染监测解决方案市场。医疗保健组织越来越需要遵守监管机构制定的严格准则和报告标准，从而推动对确保合规性的全面监控解决方案的需求。此外，基于价值的护理模式的兴起促使医疗保健提供者专注于改善患者治疗结果并降低与感染相关的成本，进一步推动感染监测技术的采用。

此外，COVID-19 疫情凸显了感染监测在管理公共卫生危机中的重要性。有效追踪和报告传染病的需求导致对监测技术的投资增加，不仅在医院，而且在公共卫生机构。行动医疗应用程式和远距医疗平台的整合也提高了感染监测解决方案的可近性和效率，使医疗保健提供者能够即时监测感染并迅速应对新出现的威胁。总之，感染监测解决方案市场将实现强劲成长，其特点是技术进步、注重法规遵从性以及致力于改善病患安全和公共健康。

我们的报告经过精心製作，为客户提供有关各个行业和市场的全面且可操作的见解。每份报告都包含几个关键部分，以确保彻底了解市场格局：

市场概览：市场的详细介绍，包括定义、分类和行业现状概述。

市场动态：深入分析影响市场成长的关键驱动因素、限制因素、机会与挑战。本节探讨技术进步、监管变化和新兴趋势等因素。

細項分析：根据产品类型、应用、最终用户和地理位置等标准将市场细分为不同的细分市场。该分析强调了每个部分的表现和潜力。

竞争格局：对主要市场参与者的全面评估，包括其市场份额、产品组合、策略倡议和财务表现。本节深入介绍领先公司的竞争动态和关键策略。

市场预测：根据历史资料和当前市场状况，预测特定时期内的市场规模和成长趋势。这包括定量分析和图形表示来说明未来的市场轨迹。

区域分析：评估不同地理区域的市场表现，确定关键市场和区域趋势。这有助于了解区域市场动态和机会。

新兴趋势与机会：识别当前和新兴的市场趋势、技术创新和潜在投资领域。本节提供未来市场发展和成长前景的见解。

区域展望
介绍
北美销售分析
- 概述、历史和预测数据销售分析
- 北美各细分市场销售分析
- 北美各国销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概述、历史和预测数据销售分析
- 欧洲各细分市场销售分析
- 欧洲各国销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概述、历史和预测数据销售分析
- 亚太地区分部销售分析
- 亚太地区国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概述、历史和预测数据销售分析
- 拉丁美洲各细分市场销售分析
- 拉丁美洲各国销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概述、历史和预测数据销售分析
- 中东和非洲分部销售分析
- 中东和非洲国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东和非洲其他地区销售分析

第 9 章：感染监测解决方案公司的竞争格局

感染监测解决方案市场竞争
伙伴关係/合作/协议
合併与收购
新产品发布
其他进展

第十章：公司简介

顶级公司市占率分析
市场集中度
Becton

公司概况
公司收入
产品
最新动态

Dickinson And Company (BD)

公司概况
公司收入
产品
最新动态

Premier Inc.

公司概况
公司收入
产品
最新动态

Wolters Kluwer NV

公司概况
公司收入
产品
最新动态

Cerner Corporation (Oracle)

公司概况
公司收入
产品
最新动态

RLDatix

公司概况
公司收入
产品
最新动态

VigiLanz Corporation

公司概况
公司收入
产品
最新动态

GOJO Industries Inc.

公司概况
公司收入
产品
最新动态

Baxter International Inc.

公司概况
公司收入
产品
最新动态

BioMéRieux SA

公司概况
公司收入
产品
最新动态

IBM Corporation (Merative)

公司概况
公司收入
产品
最新动态

Epic Systems Corporation

公司概况
公司收入
产品
最新动态

Theradoc (Premier Inc.)

公司概况
公司收入
产品
最新动态

BioVigil Healthcare Systems Inc.

公司概况
公司收入
产品
最新动态

Ecolab Inc.

公司概况
公司收入
产品
最新动态

Asolva Inc

公司概况
公司收入
产品
最新动态

注意 - 在公司简介中，财务细节和最新发展取决于可用性，对于私人公司，可能不予涵盖

简介目录图表

Product Code: VMR112115391

Global Infection Surveillance Solutions Market size is anticipated to grow from USD 587.09 Million in 2024 to USD 1834.45 Million by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 0.135% during the forecast period of 2026 to 2033.

The infection surveillance solutions market is poised for significant growth, driven by the increasing need for effective infection control and prevention strategies in healthcare settings. As the global burden of healthcare-associated infections (HAIs) continues to rise, healthcare facilities are prioritizing the implementation of robust surveillance systems to monitor and manage infection outbreaks. These solutions enable healthcare providers to collect, analyze, and report data on infection rates, facilitating timely interventions and improving patient safety. Innovations in data analytics, artificial intelligence, and machine learning are enhancing the capabilities of infection surveillance systems, allowing for real-time monitoring and predictive analytics that can identify potential outbreaks before they escalate.

Moreover, the growing emphasis on regulatory compliance and quality improvement initiatives is influencing the infection surveillance solutions market. Healthcare organizations are increasingly required to adhere to stringent guidelines and reporting standards set by regulatory bodies, driving the demand for comprehensive surveillance solutions that ensure compliance. Additionally, the rise of value-based care models is prompting healthcare providers to focus on improving patient outcomes and reducing costs associated with infections, further fueling the adoption of infection surveillance technologies.

Furthermore, the COVID-19 pandemic has underscored the importance of infection surveillance in managing public health crises. The need for effective tracking and reporting of infectious diseases has led to increased investments in surveillance technologies, not only in hospitals but also in public health agencies. The integration of mobile health applications and telehealth platforms is also enhancing the accessibility and efficiency of infection surveillance solutions, enabling healthcare providers to monitor infections in real-time and respond swiftly to emerging threats. In summary, the infection surveillance solutions market is set for robust growth, characterized by technological advancements, a focus on regulatory compliance, and a commitment to improving patient safety and public health.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Products and Services

Software
Services

By Infection Type

Surgical Site Infections
Blood Stream Infections
Urinary Tract Infections

By End User

Hospitals
Clinics
Ambulatory Surgical Centers
Other
COMPANIES PROFILED
Baxter
BD
STERIS
Getinge AB
Medtronic
Koninklijke Philips N.V.
Abbott
Medexter Healthcare
Asolva
GOJO Industries Inc
Wolters Kluwer N.V.
VigiLanz Corporation
RLDatix
Roper Technologies Inc
Health Outcomes Worldwide
OpGen Inc
Urovant Sciences and Premier
The above list can be customized.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. INFECTION SURVEILLANCE SOLUTIONS INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porters Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Products and Services
- 3.7.2 Market Attractiveness Analysis By Infection Type
- 3.7.3 Market Attractiveness Analysis By End User
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET ANALYSIS BY PRODUCTS AND SERVICES

5.1. Overview By Products and Services
5.2. Historical and Forecast Data Analysis By Products and Services
5.3. Software Historic and Forecast Sales By Regions
5.4. Services Historic and Forecast Sales By Regions

6. GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET ANALYSIS BY INFECTION TYPE

6.1. Overview By Infection Type
6.2. Historical and Forecast Data Analysis By Infection Type
6.3. Surgical Site Infections Historic and Forecast Sales By Regions
6.4. Blood Stream Infections Historic and Forecast Sales By Regions
6.5. Urinary Tract Infections Historic and Forecast Sales By Regions

7. GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET ANALYSIS BY END USER

7.1. Overview By End User
7.2. Historical and Forecast Data Analysis By End User
7.3. Hospitals Historic and Forecast Sales By Regions
7.4. Clinics Historic and Forecast Sales By Regions
7.5. Ambulatory Surgical Centers Historic and Forecast Sales By Regions

8. GLOBAL INFECTION SURVEILLANCE SOLUTIONS MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE INFECTION SURVEILLANCE SOLUTIONS COMPANIES

9.1. Infection Surveillance Solutions Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF INFECTION SURVEILLANCE SOLUTIONS INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Becton
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Dickinson And Company (BD)
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Premier Inc.
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Wolters Kluwer N.V.
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Cerner Corporation (Oracle)
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. RLDatix
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. VigiLanz Corporation
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. GOJO Industries Inc.
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Baxter International Inc.
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. BioMéRieux SA
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments
10.13. IBM Corporation (Merative)
- 10.13.1 Company Overview
- 10.13.2 Company Revenue
- 10.13.3 Products
- 10.13.4 Recent Developments
10.14. Epic Systems Corporation
- 10.14.1 Company Overview
- 10.14.2 Company Revenue
- 10.14.3 Products
- 10.14.4 Recent Developments
10.15. Theradoc (Premier Inc.)
- 10.15.1 Company Overview
- 10.15.2 Company Revenue
- 10.15.3 Products
- 10.15.4 Recent Developments
10.16. BioVigil Healthcare Systems Inc.
- 10.16.1 Company Overview
- 10.16.2 Company Revenue
- 10.16.3 Products
- 10.16.4 Recent Developments
10.17. Ecolab Inc.
- 10.17.1 Company Overview
- 10.17.2 Company Revenue
- 10.17.3 Products
- 10.17.4 Recent Developments
10.18. Asolva Inc
- 10.18.1 Company Overview
- 10.18.2 Company Revenue
- 10.18.3 Products
- 10.18.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

简介目录图表

LIST OF TABLES

Market Snapshot
Drivers: Impact Analysis
Restraints: Impact Analysis
List of Raw Material
List of Raw Material Manufactures
Analysis By Products and Services (USD MN)
Software Market Sales By Geography (USD MN)
Services Market Sales By Geography (USD MN)
Analysis By Infection Type (USD MN)
Surgical Site Infections Market Sales By Geography (USD MN)
Blood Stream Infections Market Sales By Geography (USD MN)
Urinary Tract Infections Market Sales By Geography (USD MN)
Analysis By End User (USD MN)
Hospitals Market Sales By Geography (USD MN)
Clinics Market Sales By Geography (USD MN)
Ambulatory Surgical Centers Market Sales By Geography (USD MN)
Global Infection Surveillance Solutions Market Sales By Geography (USD MN)
North America Market Analysis (USD MN)
United States Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate By Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
South East Asia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition

LIST OF FIGURES

Research Scope of Infection Surveillance Solutions Report
Market Research Process
Market Research Methodology
Global Infection Surveillance Solutions Market Size, By Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis By Products and Services
Market Attractiveness Analysis By Infection Type
Market Attractiveness Analysis By End User
Market Attractiveness Analysis By Region
Value Chain Analysis
Global Market Analysis By Products and Services (USD MN)
Software Market Sales By Geography (USD MN)
Services Market Sales By Geography (USD MN)
Global Market Analysis By Infection Type (USD MN)
Surgical Site Infections Market Sales By Geography (USD MN)
Blood Stream Infections Market Sales By Geography (USD MN)
Urinary Tract Infections Market Sales By Geography (USD MN)
Global Market Analysis By End User (USD MN)
Hospitals Market Sales By Geography (USD MN)
Clinics Market Sales By Geography (USD MN)
Ambulatory Surgical Centers Market Sales By Geography (USD MN)
Global Market Sales (USD MN)
North America Market Sales (USD MN)
Europe Market Sales (USD MN)
Asia Pacific Market Sales (USD MN)
Latin America Market Sales (USD MN)
Middle East & Africa Market Sales (USD MN)
Recent Development in Industry
Top Company Market Share Analysis
Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.